These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-Oxo-2'-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis. Yamanaka K, Takabayashi F, Mizoi M, An Y, Hasegawa A, Okada S. Biochem Biophys Res Commun; 2001 Sep 14; 287(1):66-70. PubMed ID: 11549254 [Abstract] [Full Text] [Related]
23. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats. Duchêne P, Giudicelli MD, Neau B, Gronfier A, Firmin Y, Villax P, Saivin S, Houin G. Arzneimittelforschung; 1998 Apr 14; 48(4):371-8. PubMed ID: 9608879 [Abstract] [Full Text] [Related]
24. Dynamical coupling of PBPK/PD and AUC-based toxicity models for arsenic in tilapia Oreochromis mossambicus from blackfoot disease area in Taiwan. Liao CM, Liang HM, Chen BC, Singh S, Tsai JW, Chou YH, Lin WT. Environ Pollut; 2005 May 14; 135(2):221-33. PubMed ID: 15734582 [Abstract] [Full Text] [Related]
31. Whole-body retention, excretion and metabolism of [74As]arsenic acid in the hamster. Charbonneau SM, Hollins JG, Tam GK, Bryce F, Ridgeway JM, Willes RF. Toxicol Lett; 1980 Mar 01; 5(3-4):175-82. PubMed ID: 7466843 [Abstract] [Full Text] [Related]
32. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat. Schoenig GP, Hartnagel RE, Osimitz TG, Llanso S. Drug Metab Dispos; 1996 Feb 01; 24(2):156-63. PubMed ID: 8742226 [Abstract] [Full Text] [Related]
33. Experimental studies on arsenic absorption routes in rats. Dutkiewicz T. Environ Health Perspect; 1977 Aug 01; 19():173-6. PubMed ID: 908295 [Abstract] [Full Text] [Related]
34. Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in rats after oral and intravenous doses. Meno-Tetang GM, Li H, Mis S, Pyszczynski N, Heining P, Lowe P, Jusko WJ. Drug Metab Dispos; 2006 Sep 01; 34(9):1480-7. PubMed ID: 16751263 [Abstract] [Full Text] [Related]
36. [Specific nature of the software used to construct simulations: physiologically-based toxicokinetic models]. Jałowiecki P, Kostrzewski P. Med Pr; 2001 Sep 01; 52(5):361-8. PubMed ID: 11828851 [Abstract] [Full Text] [Related]
38. A Weibull-PBPK model for assessing risk of arsenic-induced skin lesions in children. Liao CM, Lin TL, Chen SC. Sci Total Environ; 2008 Mar 25; 392(2-3):203-17. PubMed ID: 18207220 [Abstract] [Full Text] [Related]
39. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1996 Aug 25; 383():1-370. PubMed ID: 12692653 [Abstract] [Full Text] [Related]